Memo to the commissioner responsible for health
Health policy in the European Union is in a stronger situation in the wake of the COVID-19 crisis and the adoption of legislation intended to ensure greater resilience and underpin the response to the next pandemic. In this context, you face challenges of ensuring that health security stays prominent on the agenda, while furthering the reform of EU pharma legislation and doing more on non-communicable diseases, including cancers, cardiovascular disease, diabetes and Alzheimer’s. You should push for greater resources for the Health Emergency Response Authority, pursue an integrated ‘one health’ approach that takes into account the linkages between human health, animal health and ecosystems, do more to make the EU attractive for highly innovative pharma and seek to extend the Health Union project to non-communicable diseases.
Key actions:
-
Maintain health policy as a high priority
-
Boost EU attractiveness for innovative pharma
-
Extend the Health Union to non-communicable diseases
Read the full memo by clicking the download button at the top of this page.
About the authors
Related content
The European Health Data Space
The failure of global public health governance: a forensic analysis
In this Policy Contribution, we seek to understand the reasons for these failures of global collective action.
Does Europe need a Health Union?
This Policy Contribution assesses the rationale for a Health Union.
Pandemic prevention: avoiding another cycle of ‘panic and neglect’
Agreement is needed at international level on mechanisms to ensure better preparedness for the next pandemic.